A new study led by Brighton and Sussex Medical School researchers has developed a groundbreaking way to predict how well treatments work for diffuse large B-cell lymphoma (DLBCL), a common blood cancer. They created personalized simulations for each patient using genetic sequencing data to measure how genetic changes affect cancer cell behavior. This approach could […]
Continue reading Personalized simulations predict blood cancer treatment outcomes on Tech Explorist.
0 comments:
Post a Comment